Barclays’s Axcelis ACLS Stock Holding History

Barclays’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1,800	Closed	-$341K	–	5370
2026 Q2	$341K	Buy	+1,800	New	+$267K	﹤0.01%	3424

Other funds holding ACLS

Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays's ACLS Position: Q3 2026 in Review

Barclays increased its Axcelis (ACLS) stake by 127% in Q3 2026, buying an estimated $2.37M and bringing the position to 33,055 shares worth $4.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Barclays first reported a position in ACLS in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.3M in Q4 2023. 166 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

Barclays held 33,055 shares of Axcelis worth $4.34M as of Q3 2026.
Barclays bought 18,523 Axcelis shares in Q3 2026, an estimated $2.37M.
Axcelis made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2123 holding.
Barclays first reported a position in Axcelis in Q2 2013 and has held it in 52 quarters since.
Barclays's Axcelis position peaked at $24.3M in Q4 2023.
166 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.